Orthofix Medical
OFIX
136 hedge funds and large institutions have $519M invested in Orthofix Medical in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 44 increasing their positions, 55 reducing their positions, and 26 closing their positions.
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
2% more capital invested
Capital invested by funds: $511M → $519M (+$7.96M)
7.54% less ownership
Funds ownership: 103.17% → 95.62% (-7.5%)
13% less funds holding
Funds holding: 156 → 136 (-20)
20% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 55
47% less call options, than puts
Call options by funds: $40K | Put options by funds: $75K
69% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$14M |
| 2 |
BCM
Boone Capital Management
Atlanta,
Georgia
|
+$6.56M |
| 3 |
GCM
Glenview Capital Management
New York
|
+$5.3M |
| 4 |
NM
Newtyn Management
New York
|
+$3.02M |
| 5 |
ACM
AREX Capital Management
New York
|
+$2.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$19.7M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$7.66M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
-$3.65M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.53M |
| 5 |
Renaissance Technologies
New York
|
-$3.07M |
OFIX Hedge Fund Activity: Q1 2024 in Review
136 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q1 2024, worth a combined $519M — up 1.6% from $511M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of OFIX and 8 opened new positions — a net loss of 18 holders — while 55 trimmed existing stakes and 44 added.
The largest buyer was Paradigm Capital Management Inc, adding an estimated $14M. The largest seller was Morgan Stanley, cutting an estimated $19.7M.
- 136 institutional investors held Orthofix Medical (OFIX) as of Q1 2024, down from 156 in Q4 2023.
- Funds reported $519M of Orthofix Medical stock for Q1 2024, up 1.6% quarter-over-quarter.
- 8 funds opened new Orthofix Medical positions in Q1 2024 and 26 closed out, a net change of -18 holders.
- The largest Orthofix Medical buyer in Q1 2024 was Paradigm Capital Management Inc, an estimated $14M added.
- The largest Orthofix Medical seller in Q1 2024 was Morgan Stanley, an estimated $19.7M sold.
Based on aggregated 13F filings for Q1 2024.